COLL vs STE
Collegium Pharmaceutical Inc (COLL) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the COLL and STE stock pages for the full models.
Not investment advice.